Following on from the first-of-its-kind Pharmaceutical Innovation Index published by Galen Growth in November 2021, we have now assessed the Digital Health venture portfolio of each insurance company, through an analysis of their strategic focus on the customer and the potential success of the ventures contained within their portfolio.
This Index gives a snapshot of the strengths and weaknesses of the top 35 insurers’ portfolios to date and enables a qualified look forward towards choosing the next generation of Digital Health venturing partners.
